HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Denis Migliorini Selected Research

Bevacizumab (Avastin)

4/2019Exploratory Study of the Effect of IMA950/Poly-ICLC Vaccination on Response to Bevacizumab in Relapsing High-Grade Glioma Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Denis Migliorini Research Topics

Disease

32Neoplasms (Cancer)
01/2024 - 01/2015
12Glioblastoma (Glioblastoma Multiforme)
01/2024 - 01/2018
12Glioma (Gliomas)
11/2023 - 11/2013
6Brain Neoplasms (Brain Tumor)
07/2022 - 01/2015
5Hematologic Neoplasms (Hematological Malignancy)
01/2023 - 04/2016
3Hypoxia (Hypoxemia)
01/2024 - 01/2015
3Melanoma (Melanoma, Malignant)
11/2023 - 10/2016
3Astrocytoma (Pilocytic Astrocytoma)
11/2019 - 01/2017
2Lymphoma (Lymphomas)
01/2023 - 08/2022
2Neoplasm Metastasis (Metastasis)
03/2021 - 10/2016
1Epilepsy (Aura)
01/2024
1Seizures (Absence Seizure)
01/2024
1Prostatic Neoplasms (Prostate Cancer)
12/2023
1Carcinogenesis
12/2023
1Experimental Melanoma
11/2023
1Necrosis
11/2023
1Multiple Myeloma
09/2023
1Lung Neoplasms (Lung Cancer)
01/2023
1Cytokine Release Syndrome
01/2023
1Lewis Lung Carcinoma
01/2023
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2022
1COVID-19
01/2022
1Brain Edema (Cerebral Edema)
10/2020
1Bites and Stings (Sting)
10/2020
1Lymphopenia (Lymphocytopenia)
01/2020
1Oligodendroglioma
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Ependymoma
01/2018
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018
1Meningioma (Meningiomas)
10/2017
1Chordoma
01/2017
1Hemangioblastoma
01/2015

Drug/Important Bio-Agent (IBA)

11VaccinesIBA
01/2022 - 11/2013
10Chimeric Antigen ReceptorsIBA
11/2023 - 01/2016
7AntigensIBA
11/2023 - 01/2018
4Peptides (Polypeptides)IBA
01/2020 - 01/2015
3SteroidsIBA
01/2024 - 01/2020
3epidermal growth factor receptor VIIIIBA
01/2024 - 01/2015
3IMA950IBA
11/2019 - 01/2018
3Immune Checkpoint InhibitorsIBA
12/2018 - 01/2015
3Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2015
2MicroRNAs (MicroRNA)IBA
01/2024 - 01/2023
2CytokinesIBA
11/2023 - 01/2023
2Neoplasm Antigens (Tumor Antigens)IBA
11/2023 - 01/2016
2AntibodiesIBA
10/2020 - 01/2017
2Temozolomide (Temodar)FDA LinkGeneric
01/2020 - 01/2018
2Protein Subunit VaccinesIBA
11/2019 - 04/2019
2HLA Antigens (Human Leukocyte Antigens)IBA
11/2019 - 01/2019
2poly ICLCIBA
11/2019 - 04/2019
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2017 - 10/2016
1MethyltransferasesIBA
01/2024
1O-(6)-methylguanineIBA
01/2024
1Gabapentin (Neurontin)FDA LinkGeneric
01/2024
1DNA (Deoxyribonucleic Acid)IBA
01/2024
1Memantine (Namenda)FDA Link
01/2024
1Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2024
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2024
1Glutamic Acid (Glutamate)FDA Link
01/2024
1Monoclonal AntibodiesIBA
01/2024
1InterferonsIBA
01/2024
1pembrolizumabIBA
01/2024
1Anti-Bacterial Agents (Antibiotics)IBA
12/2023
1MutagensIBA
12/2023
1Androgen Receptors (Androgen Receptor)IBA
12/2023
1Interleukin-12 (IL 12)IBA
11/2023
1Immune Checkpoint ProteinsIBA
11/2023
1Programmed Cell Death 1 ReceptorIBA
01/2023
1Adenosine Triphosphate (ATP)IBA
01/2023
1Doxycycline (Periostat)FDA LinkGeneric
01/2023
1isooctyl acrylateIBA
01/2023
1RadiopharmaceuticalsIBA
07/2022
1Biomarkers (Surrogate Marker)IBA
04/2021
1Metformin (Glucophage)FDA LinkGeneric
09/2020
1Carboxymethylcellulose Sodium (Polycell)FDA Link
11/2019
1PolylysineIBA
11/2019
1Poly I-CIBA
11/2019
1Bevacizumab (Avastin)FDA Link
04/2019
1HLA-A Antigens (HLA-A)IBA
01/2019
1HLA-A*24:02 antigenIBA
01/2019
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2018
1EpitopesIBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Polysaccharides (Glycans)IBA
01/2018
1Oxidoreductases (Dehydrogenase)IBA
04/2016
1CD40 Ligand (CD40L)IBA
11/2015
1pazopanibFDA Link
01/2015
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015

Therapy/Procedure

17Therapeutics
11/2023 - 01/2015
16Immunotherapy
11/2023 - 11/2013
3Chemoradiotherapy
01/2024 - 11/2019
3Radiotherapy
01/2020 - 10/2016
2Drug Therapy (Chemotherapy)
09/2020 - 01/2020
2Cell- and Tissue-Based Therapy (Cell Therapy)
04/2016 - 01/2015
1Transplantation
12/2023
1Hematopoietic Stem Cell Transplantation
08/2022
1Oncolytic Virotherapy
10/2020
1Adjuvant Chemotherapy
01/2020
1Adjuvant Radiotherapy
10/2017